Barry A Paul (Barry Paul)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Chemotherapy Induced

Acute Lymphoblastic Leukemia

Top Venues

Life (Basel, Switzerland)

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Barry A Paul, Faiz Anwer, Shahzad Raza, Aytaj Mammadzadeh, Bayan Khasawneh, Sara Shatnawi, Joseph McGuirk, Nausheen Ahmed, Zahra Mahmoudjafari, Muhammad Mushtaq, Al-Ola Abdallah, Shebli Atrash
Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma. Cancers 16 (17) (2024)
Hamid Ehsan, Myra M Robinson, Peter M Voorhees, Kristen Cassetta, Shanice Borden, Shebli Atrash, Manisha Bhutani, Cindy Varga, Mauricio Pineda-Roman, Reed Friend, Barry A Paul
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study). Life (Basel, Switzerland) 14 (3) (2024)
Hamid Ehsan, Myra M Robinson, Peter M Voorhees, Kristen Cassetta, Shanice Borden, Shebli Atrash, Manisha Bhutani, Cindy Varga, Mauricio Pineda-Roman, Reed Friend, Barry A Paul
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study). Life (Basel, Switzerland) 14 (3) (2024)
Barry A Paul, Michaela Liedtke, Jack Khouri, Robert M Rifkin, Mitul D Gandhi, Andrew Kin, Moshe Y Levy, Rebecca W Silbermann, Francesca Cottini, Douglas W Sborov, Irwindeep Sandhu, Lyssa Villarreal, Michael Murphy, Lin Gu, Ann Chen, Nishanthan Rajakumaraswamy, Saad Z Usmani
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma. Future oncology (London, England) (2023)